Copyright © Inderes 2011 - present. All rights reserved.

Swedish Orphan Biovitrum

343.00 SEK

+4.26 %

Less than 1K followers

SOBI

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

+4.26 %
+6.00 %
+25.18 %
+12.68 %
+8.07 %
+12.75 %
+59.53 %
+112.04 %
+618.80 %

Swedish Orphan Biovitrum operates in the pharmaceutical industry and focuses on the development and distribution of medicines for rare diseases. The company's products are aimed at healthcare institutions and patients with specific medical needs. The business is global with a main presence in Europe, North America and Asia. Swedish Orphan Biovitrum was founded in 1939 and is headquartered in Stockholm, Sweden.

Read more
Market cap
122.59B SEK
Turnover
169.43M SEK
Revenue
26.03B
EBIT %
21.61 %
P/E
30.17
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5/2
2026

Annual report '25

28/4
2026

Interim report Q1'26

6/5
2026

General meeting '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.